People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Medable Inc. | — | Other Health Care | Series D+ | $501.0M | $5.4B | 2015 |
| Carna Inc. | — | Biotechnology | Seed | $3.4M | $12.4M | 2025 |
Michelle Longmire at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michelle Longmire on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy Smith | 1 | 5 |
| Thomas Dolan | 1 | 4 |
| Mahkam Zanganeh | 1 | 3 |
| Robert Duggan | 1 | 3 |
| David Vogel | 1 | 2 |
| Salvatore Viscomi | 1 | 2 |
| Young A. Sohn | 1 | 1 |
| Anna A. Long | 1 | 1 |
| David A. Hartwig | 1 | 1 |
| Richard A. Lim | 1 | 1 |
| Timothy R. Smith | 1 | 1 |
| Perry A. Robinson | 1 | 1 |
| Mary Sallah | 1 | 1 |
| Boris Berat | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.